.Attribute Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective asks for introduction of clients with MASLD as well as dimension of liver end results in cardio-- kidney-- metabolic trials, when data recommend mechanistically probable benefits and scientific safety and security-- as well as outlines factors for trial concept and regulative commendation.